<DOC>
	<DOC>NCT00232141</DOC>
	<brief_summary>Study to determine if pregabalin is more effective than placebo in treating subjects with nerve pain associated with HIV neuropathy.</brief_summary>
	<brief_title>Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Subjects with confirmed diagnosis of HIV infection HIVassociated neuropathic pain (nerve pain) for at least 3 months prior to study start subjects with moderate to severe pain subjects on stable HIV and pain medications (some medications are not allowed to be taken while participating in the study). Pregnant or breast feeding females subjects using street drugs or alcohol abusers during the study subject's on antidiabetic medications use of neuroregenerative agents or neurotoxic chemotherapeutic agents 3 months prior to study start and throughout the study use of neurotoxic drugs (other than Ddrugs) within a month prior to study start and throughout the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>